Basic Information
Biogenics, established in April 1997, is a partner with innovative concepts in pharmaceutical contract marketing. This new idea attracted many multinational pharmaceutical companies to Biogenics as clients. In March 1998, Biogenics signed its first agreement with Novartis Pharma (formerly Sandoz), covering 10 products. Soon after, similar agreements were reached with Abbott, Pfizer, Eli Lilly, Janssen Cilag, and UK's Gold Shield.